Bionomics Accounts Payable from 2010 to 2024

BNOX Stock  USD 0.28  0.02  6.67%   
Bionomics Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 1.6 M in 2024. Accounts Payable is the amount Bionomics Ltd ADR owes to suppliers or vendors for products or services received but not yet paid for. It represents Bionomics' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2001-06-30
Previous Quarter
2.2 M
Current Value
1.3 M
Quarterly Volatility
1.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.37. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
  
Check out the analysis of Bionomics Correlation against competitors.

Latest Bionomics' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Bionomics Ltd ADR over the last few years. An accounting item on the balance sheet that represents Bionomics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Bionomics ADR are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Bionomics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Bionomics Accounts Payable Regression Statistics

Arithmetic Mean1,817,749
Geometric Mean1,563,470
Coefficient Of Variation54.64
Mean Deviation801,420
Median1,564,728
Standard Deviation993,130
Sample Variance986.3B
Range3.4M
R-Value(0.30)
Mean Square Error964B
R-Squared0.09
Significance0.27
Slope(67,500)
Total Sum of Squares13.8T

Bionomics Accounts Payable History

20241.6 M
20232.2 M
20221.4 M
20211.1 M
2020772.9 K
2019870.6 K
2018844.4 K

About Bionomics Financial Statements

Bionomics investors use historical fundamental indicators, such as Bionomics' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable2.2 M1.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.